Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Im loving my results already down 9 pounds in the first month
17 Rosenstock, J., et al., Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Serious side effects are also slightly more common on tirzepatide
References and where to read more For deeper reading, look for human randomized trials and metaanalyses that summarize weight and performance outcomes, and explore brand research pages that publish trial summaries and COAs
Gastric Emptying Delay: Slows down food transit through the upper gastrointestinal tract, maintaining a prolonged sensation of fullness
Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats
US$ 21.49
US$ 22.29
US$ 22.61
US$ 21.19
US$ 23.57
US$ 24.37
